Skip to Content


In the US, Vardenafil (vardenafil systemic) is a member of the drug class impotence agents and is used to treat Erectile Dysfunction.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Peripheral vasodilator

Treatment of erectile dysfunction

Phosphodiesterase type 5 (PDE5) inhibitor

Chemical Names

1-[[3-(3,4-dihydro-5-metyl-4-oxo-7-propylimidazo[5,1-f][1,2,4]triazin-2-yl)-4-etoxyphenyl]sulfonyl]-4-etylpiperazin (IUPAC)

1-[[3-(3,4-dihydro-5-metyl-4-oxo-7-propylimidazo[5,1-f]-as-triazin-2-yl)-4-etoxyphenyl]sulfonyl]-4-etylpiperazine (WHO)

Piperazine, 1-[[3-(1,4-dihydro-5-metyl-4-oxo-7-propylimidazo[5,1-f][1,2,4]triazin-2-yl)-4-etoxyphenyl]sulfonyl]-4-etyl-

Foreign Names

  • Vardenafilum (Latin)
  • Vardenafil (German)
  • Vardénafil (French)
  • Vardenafil (Spanish)

Generic Names

Brand Names

  • Levitra
    Bayer, Denmark; Bayer, Georgia; Bayer, Lebanon; Bayer, Peru; Bayer, Slovakia; Bayer, Vietnam; Bayer Healthcare, Indonesia; Bayer Healthcare, Malaysia; Bayer Schering, Taiwan
  • Vivanza
    Bayer, Poland
  • Levitra ODT
    Bayer, Hong Kong
  • Levitra
    Bayer, Bosnia & Herzegowina; Bayer, Belgium; Bayer, Bahrain; Bayer, Brazil; Bayer, Canada; Bayer, Chile; Bayer, Colombia; Bayer, Costa Rica; Bayer, Ecuador; Bayer, Egypt; Bayer, Spain; Bayer, United Kingdom; Bayer, Georgia; Bayer, Greece; Bayer, Guatemala; Bayer, Hong Kong; Bayer, Honduras; Bayer, Croatia (Hrvatska); Bayer, Haiti; Bayer, Hungary; Bayer, Ireland; Bayer, Italy; Bayer, Nicaragua; Bayer, Netherlands; Bayer, New Zealand; Bayer, Oman; Bayer, Panama; Bayer, Philippines; Bayer, Poland; Bayer, Portugal; Bayer, Romania; Bayer, Sweden; Bayer, El Salvador; Bayer, Turkey; Bayer de México, Mexico; Bayer HealthCare, Finland; Bayer HealthCare, Russian Federation; Bayer Pharma, Austria; Bayer Pharma, Israel; Bayer Pharma AG, Norway; Bayer Santé, France; Bayer Schering, Australia; Bayer Schering, China; Bayer Schering, Czech Republic; Bayer Schering, Lithuania; Bayer Schering, Serbia; Bayer Schering, South Africa; Bayer Thai Co Ltd, Thailand; FourPharma CRO, Italy; GlaxoSmithKline, Latvia; GlaxoSmithKline, United States; Jenapharm, Germany; Schering-Plough, United States
  • Levitra Bcnfarma
    Bcnfarma, Spain
  • Levitra Euromedicines
    Euromedicines, Spain
  • Levitra Gervasi
    Gervasi, Spain
  • Levitra ODT
    Bayer, Colombia; Bayer HealthCare, Russian Federation
  • Powerecta
    Eva, Egypt
  • Rectivard
    Marcyrl, Egypt
  • Solvetra
    Next Ph, Egypt
  • Staxyn
    Bayer, Canada; GlaxoSmithKline, United States
  • Vivanza
    Bayer, Belgium; Bayer, Spain; Bayer, Greece; Bayer, Netherlands; Bayer, Portugal; Bayer Pharma, Austria; Bayer Schering, Lithuania; Berlis, Switzerland


BANBritish Approved Name
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.